Clare Ozawa

Clare Ozawa

Director/Board Member at
Inception IBD, Inc.
52 year
Health Technology
Commercial Services
Consumer Services

Profile

Clare R.
Ozawa
is currently Director at Inception Sciences, Inc. since 2017, Director at Inception IBD, Inc., 858 Therapeutics, Inc., Jengu Therapeutics, Inc., Capsida Biotherapeutics, Inc., Stablix, Inc., and Kate Therapeutics, Inc., and Managing Director at Versant Venture Management LLC since 2017.
Former roles include Chief Executive Officer at McKinsey & Co., Inc. in 2006, Chief Executive Officer at Novartis Pharma AG from 2006 to 2008, Independent Director at Oyster Point Pharma, Inc. from 2019 to 2023, Director at Contineum Therapeutics, Inc., and Investment Professional at Versant Venture Management LLC from 2008 to 2010.
Education includes undergraduate studies at Stanford University and a doctorate from Stanford University School of Medicine conferred in 2002.

Clare Ozawa active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member 2014-05-31
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Private Equity Investor 2016-12-31

Former positions of Clare Ozawa

CompaniesPositionEnd
OYSR POIN Director/Board Member 2023-01-02
░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Clare Ozawa's experience

Training of Clare Ozawa

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

86

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Commercial Services

Consumer Services

Finance

Health Technology

Consumer Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology